The weakest link – biopharma workforce development

Killian O’Driscoll, Director of Projects at the National Institute for Bioprocessing Research and Training (NIBRT), highlights the plight of a future skills shortage in the global biopharma industry as state-of-the-art therapy production evolves at a rapid pace.

A KEY PRINCIPLE in Annex 1 of the Rules Governing Medicinal Products in the European Union (Manufacture of Sterile Medicinal Products) states “…Much depends on the skills, training and attitudes of the personnel involved…”. However, the demand for biopharma talent has never been more acute – posing a threat to the robustness of global supply chains.